Unternehmen
Catalyze B.V.
Catalyze B.V. – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Targeting RNA as an approach for treating retinal disease Today, vision impairment up to total blindness represents an increasing global problem with significant socia…
- Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity The current global COVID-19 pandemic has caused severe health and socio-economic challenges. Despite signific…
- Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments Oral delivery of peptide-analogues (a macromolecule) is one of the great challenges in pharmaceutical researc…
- "A novel multi-functional elastin-like recombinant hydrogel for the prevention of scar tissue formation following a myocardial infarction: ""ELR-SCAR""" The ELR SCAR project aims to complete preclinical validation of a novel biomaterial, an elastin-like recombin…
- Development of a smart shape-memory sensor for biological pressure monitoring applications Hypertension is the leading global contributor to premature death, accounting for over 9M deaths worldwide ea…
- Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine Aim: The SILKink project aims to develop a breakthrough biocompatible hydrogel, i.e., a bioink, to 3D print b…
- Advanced Engineering of Nitric Oxide Based Therapeutics for Triple Negative Breast Cancer Training Network NO-CANCER-NET will focus on Triple Negative Breast Cancer (TNBC) and Nitric Oxide (NO)-related therapeutic de…
- Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations Rare Eye Diseases (REDs) are a major cause of visual impairment and blindness in Europe, affecting patients o…